Component

Circulating and urinary glycation markers

Independent biological entity. Read linked claims for experimental scope and context.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The same trial found no significant reduction in plasma/urinary AGE markers or measured endothelial and inflammatory biomarkers.

    Experimental context and source evidence
    experimental_model
    Same 82-person trial, biomarker report.
    exposure
    Same 900 mg/day, 12-week benfotiamine trial as b1-alkhalaf2010; not an independent sample.
    limitations
    Not an independent cohort; systemic biomarkers do not directly measure retinal pathway flux.
    nutrient_topic
    Thiamine research collection; topical membership is not evidence of a direct dietary effect. · Thiamine (vitamin B1)
    organism
    Homo sapiens
    plain_language
    The proposed vascular pathways did not show a clear biomarker response in these participants.
    primary_references
    [b1-alkhalaf2012] Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy (2012). https://pubmed.ncbi.nlm.nih.gov/22792314/ DOI: 10.1371/journal.pone.0040427
    tissue_or_cell_type
    Plasma/urine

    Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1867–1877

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Same 82-person trial, biomarker report. · source_derived_draft · unverified_draft

    ### b1-benfotiamine-human-age-null The same trial found no significant reduction in plasma/urinary AGE markers or measured endothelial and inflammatory biomarkers. Condition category: normal nutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect. plain_language: The proposed vascular pathways did not show a clear biomarker response in these participants. organism: Homo sapiens tissue_or_cell_type: Plasma/urine experimental_model: Same 82-person trial, biomarker report. limitations: Not an independent cohort; systemic biomarkers do not directly measure retinal pathway flux. exposure: Same 900 mg/day, 12-week benfotiamine trial as b1-alkhalaf2010; not an independent sample. [b1-alkhalaf2012] Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy (2012). https://pubmed.ncbi.nlm.nih.gov/22792314/ DOI: 10.1371/journal.pone.0040427
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards